Bosch has announced its 3rd generation SiC MOSFETs, based on the company's dual-channel trench SiC architecture with lower on ...

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

ABSTRACT: In this study, a comparison of 5 nm PDSOI and FDSOI n-MOSFETs with SiO2 and high-k gate dielectrics is carried out using Silvaco TCAD ATLAS platform with necessary models. SOI architectures ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. After the ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Structure Therapeutics ...

Just two of the nine shoes leading Nike’s reorganized running lineup have yet to release. Both of those come from the Structure franchise, and one has been confirmed for an early 2026 release. The ...

The circuit presented by Cor Van Rij for characterizing JFETs is a clever solution. Noteworthy is the use of a five-pin test socket wired to accommodate all of the possible JFET pinout arrangements.

Abstract: In specialized fields such as fusion energy, aerospace, and nuclear power, radiation detectors are often required to operate reliably at high temperatures. Wide-bandgap semiconductors offer ...

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...